The short version
11 companies supply this market — deep enough that no single failure threatens the supply. One of its named manufacturing plants, Nephron SC, LLC, failed FDA inspectionwithin the last two years — the agency’s most serious outcome. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want. Historically, drugs in this position went on to a new shortage within 90 days about 1.5% of the time — roughly 10× the typical drug (0.1%).
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.